Back to search

Article

A CAR-T response prediction model for r/r B-NHL patients based on a T-cell subset nomogram

2023-04-13

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold> Chimeric antigen receptor-modified T-cells (CAR-T) have shown good clinical benefit in the treatment of patients with refractory or relapsed B-cell non-Hodgkin’s lymphoma (r/r B-NHL). However, the factors that influence the clinical response to CAR-T therapy are not fully understood. The aim of this study is to investigate the independent influencing factors of t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7556b1f5-0fcd-5d17-a92f-209ab4809c85
DOI
10.21203/rs.3.rs-2728417/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A CAR-T response prediction model for r/r B-NHL patients based on a T-cell subset nomogramDOI 10.21203/rs.3.rs-2728417/v1
Future perspectives on novel CAR-T therapeutics beyond CD19 and BCMA in onco-hematologySemantic proximity
Factors associated with treatment response to CD19 CAR-T therapy among a large cohort of B cell acute lymphoblastic leukemia.Semantic proximity
Comparative Effectiveness of CAR T-Cell Therapy versus Blinatumomab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A prospective cohort studySemantic proximity
Analysis of high-risk factors and prognosis of early relapse in 104 patients with natural killer/T-cell lymphoma: a single-center retrospective studySemantic proximity
The frequency of differentiated CD3+CD27-CD28- T cells predicts response to CART cell therapy in diffuse large B-cell lymphomaSemantic proximity
Lenalidomide overcomes the resistance to third-generation CD19-CAR-T cell therapy in preclinical models of diffuse large B-cell lymphomaSemantic proximity
Periphery TH/TS ratio and TP53 mutation predict the efficacy of ICI-based therapy in advanced non-small cell lung cancer with high PD-L1 expressionSemantic proximity
Tandem CD19/CD22 CAR-T cells conquer high-risk cytogenetics and acquire complete remission in r/r B-ALL patientsSemantic proximity
CD19-directed CAR T-cell therapy in B-cell NHLSemantic proximity
Outcomes of Wild Type and TP53-Mutated B Cell Malignancy Patients Receiving CAR-T Cell Therapy: A Systematic Review and Meta-Analysis.Semantic proximity
Analysis of causes for poor persistence of CAR-T cell therapy in vivoSemantic proximity
Integrating genomic features for prognosis in Chinese patients with B-cell lymphoma following chimeric antigen receptor T-cell therapy.Semantic proximity
Select a neighboring publication to make it the new centre.